肺癌的综合影像诊断进展  

The New Progress of Integrated Imaging Techniques on Diagnosing Lung Carcinoma

作　　者：车舒平 孙夕林[1] 鄢英男 申宝忠[1] CHE Shu-ping, SUN Xi-lin, YAN Ying-nan, SHEN Bao-zhong(Department of Radiology, the Forth AttTliated Hospital, Harbin, Heilongjiang, 150001, Chin)

机构地区：[1]哈尔滨医科大学附属第四医院医学影像中心,黑龙江哈尔滨150001

出　　处：《现代生物医学进展》2018年第2期392-396,共5页Progress in Modern Biomedicine

基　　金：国家重点基础研究发展计划(2015CB931800);国家自然科学基金项目(81130028;31210103913;81471724;81101088);黑龙江省自然科学基金委留学归国科学基金项目(LC2013C26);黑龙江省级领军人才梯队后备带头人资助资金项目;哈尔滨市科技创新人才研究专项资金(2014RFQGJ011);哈尔滨医科大学伍连德青年科学基金项目(WLD-QN1119);哈尔滨医科大学附属第四医院杰出青年基金;黑龙江省高校分子影像重点实验室基金项目

摘　　要：肺癌的患病率及死亡率呈逐年增长趋势,影像学对肺癌的诊断及疗效监测至关重要。随着影像学的飞速发展和分子影像的崛起,临床用于肺癌诊断的成像方式日趋丰富,其中功能成像及分子成像的重要性日益增加。本文就各种成像方式关于肺癌检测、筛查、分期及疗效监测的进展进行综述。The morbidity and mortality of lung carcinoma are progressively increasing year by year, medical imaging has an important role in the multidisciplinary management of primary lung cancer. Recently, with the rapid development of radiology and molecular imaging, the image method to clinical diagnoce is increasingly abundant, the importance of functional imaging and molecular imaging is increasing. This article reviews the current state imaging modalities used for the evaluation, staging and post-treatment follow-up and surveillance of lung cancers.

关 键 词：肺癌 影像学 CT MR PET 分子影像 

分 类 号：R445.2[医药卫生—影像医学与核医学]